Abatacept/therapeutic useRefine your research by the most used items
Author / Editor
- Finckh, Axel (3)
- Allali, Danièle (1)
- Askling, Johan (1)
- Blondon, Marc (1)
- Brulhart, Laure Sophie (1)
- Canhao, Helena (1)
- Canhão, H (1)
- Ciurea, A (1)
- Courvoisier, D S (1)
- Dixon, William G (1)
Document type
Full text accessibility
Full text version
Licence
Subject
Highlights
Show items per page
remove all| Title | Authors / Editors | Date | |
|---|---|---|---|
 |
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland | Finckh, Axel; Tellenbach, C; Herzog, L; Scherer, A; ... Zufferey, P | 2020 |
|
|
Allergologie-immunologie - Prise en charge de l'artérite gigantocellulaire en 2019 | Allali, Danièle; Blondon, Marc; Roux-Lombard, Pascale; Spoerl, David | 2020 |
|
|
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers | Mercer, Louise K; Askling, Johan; Raaschou, Pauline; Dixon, William G; ... Listing, Joachim | 2017 |
|
|
Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis | Gottenberg, J E; Courvoisier, D S; Hernandez, M V; Iannone, F; ... Finckh, Axel | 2016 |
